Stock listing
Island Pharmaceuticals Ltd
Selected listing: ILA · ASX · AUD · AU
Island Pharmaceuticals Ltd (ASX:ILA), Health Technology. Latest release Oct 2, 2026: Galidesivir GMP manufacturing commences.
- Ticker
- ASX:ILA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- ASX
- Currency
- AUD
About Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd, trading under the ticker ILA, is a public company listed on the Australian market. Island Pharmaceuticals is focused on developing innovative solutions in the pharmaceutical sector.
Latest news from Island Pharmaceuticals Ltd
Galidesivir GMP manufacturing commences
October 1, 2026
Pivotal Marburg data secured for Galidesivir FDA pathway
August 30, 2026
Island boosts Galidesivir supply as Ebola surges
August 20, 2026
Texas Biomed SOW accelerates pivotal FDA pathway
July 12, 2026
Investor Presentation - Ebola Clinical Program
July 7, 2026
Research Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd company profile
View the public company page for Island Pharmaceuticals Ltd on 6ix.
Island Pharmaceuticals Ltd news
Read company news and market updates connected to Island Pharmaceuticals Ltd.
Island Pharmaceuticals Ltd investor events
Find investor webinars, events, and replay context for Island Pharmaceuticals Ltd.
Alternate listings
7X0:FWB
DE · EUR
Alternate listing for Island Pharmaceuticals Ltd; the primary context on this page is ILA:ASX.
7X0:DUS
DE · EUR
Alternate listing for Island Pharmaceuticals Ltd; the primary context on this page is ILA:ASX.
ILPLF:OTC
US · USD
Alternate listing for Island Pharmaceuticals Ltd; the primary context on this page is ILA:ASX.
7X0:TRADEGATE
DE · EUR
Alternate listing for Island Pharmaceuticals Ltd; the primary context on this page is ILA:ASX.